Page last updated: 2024-09-02

3,5-dihydroxyphenylglycine and vu0424465

3,5-dihydroxyphenylglycine has been researched along with vu0424465 in 1 studies

Compound Research Comparison

Studies (3,5-dihydroxyphenylglycine)	Trials (3,5-dihydroxyphenylglycine)	Recent Studies (post-2010) (3,5-dihydroxyphenylglycine)	Studies (vu0424465)	Trials (vu0424465)	Recent Studies (post-2010) (vu0424465)
22	0	10	6	0	6

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blobaum, AL; Byers, FW; Cho, HP; Conn, PJ; Garcia-Barrantes, PM; Lindsley, CW; Locuson, CW; Niswender, CM; Rook, JM; Xiang, Z	1

Other Studies

1 other study(ies) available for 3,5-dihydroxyphenylglycine and vu0424465

Article	Year
Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu1), Based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and M Journal of medicinal chemistry, 2015, Oct-22, Volume: 58, Issue:20 Topics: Animals; Central Nervous System; Epilepsy; GABA Agonists; GABA Modulators; Half-Life; Humans; Molecular Conformation; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Schizophrenia; Structure-Activity Relationship	2015

Article

Year

Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu1), Based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and M

Journal of medicinal chemistry, 2015, Oct-22, Volume: 58, Issue:20

Topics: Animals; Central Nervous System; Epilepsy; GABA Agonists; GABA Modulators; Half-Life; Humans; Molecular Conformation; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Schizophrenia; Structure-Activity Relationship

2015